Sumant Ramachandra is the founder of ImmPACT Bio. ImmPACT Bio has raised $129M in total funding. Latest round: Series B. Backed by venBio Partners.
Sumant Ramachandra is the Co-founder, President, and Chief Executive Officer (CEO) of ImmPACT Bio, a biotechnology company focused on developing cell therapies for cancer treatment. He joined ImmPACT Bio's board of directors and became CEO in January 2022, bringing experience from previous roles at Baxter and Pfizer.
Full founder directory · Investor directory · Company funding database · Fundraising library